27
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Frequency of exposure to arboviruses and characterization of Guillain Barré syndrome in a clinical cohort of patients treated at a tertiary referral center in Brasília, Federal District

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Background:

          Guillian Barré syndrome (GBS) is an acute autoimmune polyradiculoneuropathy often associated with previous exposure to infectious agents.

          Methods:

          A clinical cohort of 41 patients with GBS admitted to the Base Hospital Institute of the Federal District between May 2017 and April 2019 was followed up for 1 year. Serological tests for arbovirus detection and amplification of nucleic acids using polymerase chain reaction for zika virus (ZIKV), dengue virus (DENV), and chikungunya virus (CHIKV) were performed.

          Results:

          The cohort consisted of 61% men with a median age of 40 years, and 83% had GBS-triggering events. A total of 54% had Grade 4 disability, 17% had Grade 3, 12% had Grade 2, 10% had Grade 5, and 7% had Grade 1. The classic form occurred in 83% of patients. Nerve conduction evaluations revealed acute demyelinating inflammatory polyneuropathy (51%), acute motor axonal neuropathy (17%), acute sensory-motor neuropathy (15%), and indeterminate forms (17%). Four patients were seropositive for DENV. There was no laboratory detection of ZIKV or CHIKV infection. Ninety percent of patients received human immunoglobulin. Intensive care unit admission occurred in 17.1% of the patients, and mechanical ventilation was used in 14.6%. One patient died of Bickerstaff’s encephalitis. Most patients showed an improvement in disability at 10 weeks of follow-up.

          Conclusions:

          GBS in the Federal District showed a variable clinical spectrum, and it was possible to detect recent exposure to DENV.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: not found
          • Article: not found

          An update on Zika virus infection

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

            Guillain-Barré syndrome (GBS) is a potentially life-threatening postinfectious disease characterized by rapidly progressive, symmetrical weakness of the extremities. About 25% of patients develop respiratory insufficiency and many show signs of autonomic dysfunction. Diagnosis can usually be made on clinical grounds, but lumbar puncture and electrophysiological studies can help to substantiate the diagnosis and to differentiate demyelinating from axonal subtypes of GBS. Molecular mimicry of pathogen-borne antigens, leading to generation of crossreactive antibodies that also target gangliosides, is part of the pathogenesis of GBS; the subtype and severity of the syndrome are partly determined by the nature of the antecedent infection and specificity of such antibodies. Intravenous immunoglobulin and plasma exchange are proven effective treatments but many patients have considerable residual deficits. Discrimination of patients with treatment-related fluctuations from those with acute-onset chronic inflammatory demyelinating polyneuropathy is important, as these conditions may require different treatments. Novel prognostic models can accurately predict outcome and the need for artificial ventilation, which could aid the selection of patients with a poor prognosis for more-individualized care. This Review summarizes the clinical features of and diagnostic criteria for GBS, and discusses its pathogenesis, treatment and prognosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay.

              The dengue (DEN) viruses are positive-strand RNA viruses in the genus Flavivirus. Dengue fever and dengue hemorrhagic fever/dengue shock syndrome are important human arboviral diseases caused by infection with one of four closely related but serologically distinct DEN viruses, designated DEN-1, DEN-2, DEN-3, and DEN-4 viruses. All four DEN serotypes are currently co-circulating throughout the subtropics and tropics, and genotypic variation occurs among isolates within a serotype. A real-time quantitative nucleic acid amplification assay has been developed to detect viral RNA of a single DEN virus serotype. Each primer-probe set is DEN serotype specific, yet detects all genotypes in a panel of 7 to 10 representative isolates of a serotype. In single reactions and in fourplex reactions (containing four primer-probe sets in a single reaction mixture), standard dilutions of virus equivalent to 0.002 PFU of DEN-2, DEN-3, and DEN-4 viruses were detected; the limit of detection of DEN-1 virus was 0.5 equivalent PFU. Singleplex and fourplex reactions were evaluated in a panel of 40 viremic serum specimens with 10 specimens per serotype, containing 0.002 to 6,000 equivalent PFU/reaction (0.4 to 1.2 x 10(6) PFU/ml). Viral RNA was detected in all viremic serum specimens in singleplex and fourplex reactions. Thus, this serotype-specific, fourplex real-time reverse transcriptase PCR nucleic acid detection assay can be used as a method for differential diagnosis of a specific DEN serotype in viremic dengue patients and as a tool for rapid identification and serotyping of DEN virus isolates.
                Bookmark

                Author and article information

                Journal
                Rev Soc Bras Med Trop
                Rev Soc Bras Med Trop
                rsbmt
                Revista da Sociedade Brasileira de Medicina Tropical
                Sociedade Brasileira de Medicina Tropical - SBMT
                0037-8682
                1678-9849
                08 April 2022
                2022
                : 55
                : e0306-2021
                Affiliations
                [1 ] Universidade de Brasília, Faculdade de Medicina, Núcleo de Medicina Tropical, Brasília, DF, Brasil.
                [2 ] Instituto Hospital de Base do Distrito Federal, Unidade de Infectologia, Brasília, DF, Brasil.
                [3 ] Instituto Hospital de Base do Distrito Federal, Unidade de Neurologia, Brasília, DF, Brasil.
                Author notes
                Corresponding author: Luíza Morais de Matos. e-mail: l.amatos@ 123456hotmail.com

                Authors’ contribution: LMM: Conception and design of the study, Acquisition of data, Analysis and interpretation of data, Drafting the article, Final approval of the version to be submitted; EPM: Acquisition of data, Analysis and interpretation of data, Drafting the article, Final approval of the version to be submitted; ATB: Acquisition of data, Analysis and interpretation of data, Drafting the article; ABP: Acquisition of data, Analysis and interpretation of data; VML: Acquisition of data, Drafting the article; RNMF: Acquisition of data, Analysis and interpretation of data; JPLM: Acquisition of data; GASR: Conception and design of the study, Analysis and interpretation of data, Drafting the article, Final approval of the version to be submitted.

                Conflict of Interest: The authors declare that there is no conflict of interest.

                Author information
                http://orcid.org/0000-0002-4240-4041
                http://orcid.org/0000-0003-4185-251X
                http://orcid.org/0000-0001-7393-1488
                http://orcid.org/0000-0002-5575-872X
                http://orcid.org/0000-0001-6584-9572
                http://orcid.org/0000-0003-2978-0269
                http://orcid.org/0000-0001-7662-7692
                http://orcid.org/0000-0003-1425-926X
                Article
                00308
                10.1590/0037-8682-0306-2021
                9009888
                35416870
                41f21e81-4307-4325-a473-c690e2a1a500

                This is an open-access article distributed under the terms of the Creative Commons Attribution License

                History
                : 10 June 2021
                : 26 January 2022
                Page count
                Figures: 3, Tables: 2, Equations: 0, References: 40
                Categories
                Major Article

                guillain barré syndrome,arbovirus,dengue,clinical cohort,diagnosis,prognosis

                Comments

                Comment on this article